Pulsatile Chronotherapeutic Drug Delivery for Controlling Early Morning Surge in Blood Pressure; Effect of Coating on Eplerenone In-vitro, In- vivo Release and Urinary Na/K Ratio

Authors

  • Maha Abd El hameed Marzouk Department of Pharmaceutics and pharmaceutical technology
  • Manal Kamal Darwish Department of Pharmaceutics and pharmaceutical technology, Faculty of Pharmacy (girls), Al-Azhar University, Cairo, Egypt
  • Ghada Ehab Yassin Department of Pharmaceutics and pharmaceutical technology, Faculty of Pharmacy (girls), Al-Azhar University, Cairo, Egypt; Department of Pharmaceutics, Faculty of Pharmacy, October University for Modern Sciences and Art (MSA), Giza, Egypt
  • Marwa Adel Abd El-Fattah Department of Pharmaceutics and pharmaceutical technology, Faculty of Pharmacy (girls), Al-Azhar University, Cairo, Egypt https://orcid.org/0000-0002-5275-0810

DOI:

https://doi.org/10.1590/s2175-97902022e19306

Keywords:

Eplerenone, pH-independent chronotherapeutic delivery system, Early morning hypertension, In-vivo study, Urinary Na/K ratio

Abstract

The objective of the present study was to develop time delayed chronotherapeutic formulation of Eplerenone (Ep) to provide rapid drug release after a pre-determined lag time for the treatment of early morning hypertension. Cyclodextrin complexation was used to prepare fast release Ep core tablets. The developed core tablets were then coated with different rate-controlling polymers using compression coating technique. The developed tablets were evaluated for hardness, friability, drug content and swelling index. The in-vitro drug release was carried out to study the effect of different coating materials on drug release and lag time. Tablets selected for stability study were those showing lag time of 5-7 hours followed by complete drug release; F2, F3, F7, F8, and F12. The in-vivo study was carried out on tablets with the highest t90 as compared to commercial tablets after being administered to healthy human volunteers where plasma Ep and urinary Na/K ratio were determined. Results suggested that this approach was able to provide delayed release Ep formulations that will be useful for patients with morning surge in blood pressure.

Downloads

Download data is not yet available.

References

Abdelbary A, Bendas ER, Ramadan AA, Mostafa DA. Pharmaceutical and pharmacokinetic evaluation of a novel fast dissolving film formulation of flupentixol dihydrochloride. AAPS PharmSciTech. 2014;15(6):1603-10.

Airemwen CO, Uhumwangho MU, Ofeimum J, Asemwota IO, Isibor K. Formulation and evaluation of theophylline timed release tablets for chronotherapeutic drug delivery using natural gums. Saudi J Med Pharm Sci. 2017;3(8):832-837.

Al-Shahrani S, Ansari MJ. Solubility evaluations of osimertinib mesylate in physiological buffers. Indo Am J Pharm Sci. 2018;5(4):2610-5.

Balaji AN, Umashankar MS, Kavitha B. Liquisolid technology-A latest review. Int J Appl Pharm. 2014;6(1):11-9.

Banode VS, Khedekar PB, Tarte PS. Spectrophotometric estimation of Eplerenone in bulk drug and tablets. Int J ChemTech Res. 2011;3(1):398-402.

Chen J, Qin X, Zhong S, Chen S, Su W, Liu Y. Characterization of curcumin/cyclodextrin polymer inclusion complex and investigation on its antioxidant and antiproliferative activities. Molecules. 2018;23(1179):1-13.

Domala R, Eedara BB, Dhurke RK. Development of Pulsatile Drug Delivery System Using Novel Solubilizers for Antihypertensive Drug. Int J Pharm Pharm Sci. 2014;6(5):659-664.

Doroodm MM, FatemehGhasemi F. Atomic emission spectro electrochemistry as a sensitive technique for trace and ultra-trace determination of metal species. Int J Adv Eng, Manage Sci. 2017;3(2):122-133.

Dumpa NR, Sarabu S, Bandari S, Zhang F, Repka MA. Chronotherapeutic drug delivery of Ketoprofen and ibuprofen for improved treatment of early morning stiffness in arthritis using hot-melt extrusion technology. AAPS PharmSciTech . 2018;19(6):2700-2709.

Eudy RJ, Sahasrabudhe V, Sweeney K, Tugnait M, King-Ahmad A, Near K, et al. The use of plasma aldosterone and urinary sodium to potassium ratio as translatable quantitative biomarkers of mineralocorticoid receptor antagonism. J Transl Med. 2011;9(180):1-11.

Formulating Controlled Release Tablets and Capsules with Carbopol ®* Polymers, Pharmaceutical Bulletin, Pharmaceutical Bulletin 31 Edition: May 31,2011. controlled release tablets and capsules with Carbopol®* Polymers. 2011. Accessed from https://www.lubrizol.com/-/media/ Lubrizol/Life-Sciences/Documents/Literature/Bulletin-31---Formulating-Controlled-Release-Tablets-and-Capsules-with-Carbopol.pdf

» https://www.lubrizol.com/-/media/ Lubrizol/Life-Sciences/Documents/Literature/Bulletin-31---Formulating-Controlled-Release-Tablets-and-Capsules-with-Carbopol.pdf

Garrido EM, Rodrigues D, Milhazes N, Borges F, Garrido J. Molecular encapsulation of herbicide terbuthylazine in native and modified β-cyclodextrin. J Chem. 2017;(1)1-9.

Harikrishnan V, Madhusudhan S, Santhiagu A. Design and evaluation of controlled release buccal tablet of tizanidine hydrochloride using natural polymer guar gum. Der Pharmacia Lettre. 2016;8(1):73-79.

Hasan HJ, Khalil YI. Development and evaluation of press coated tablets of fexofenadine hydrochloride as pulsatile delivery system. Int J Pharm Sci Rev Res. 2017;42(1):265-273.

Higuchi T, Connors KA. Phase solubility techniques. Adv Anal Chem Instrum. 1965;4(2):117-212.

Inoue Y, Narumi S, Mitsumori A, Murata I, Kanamoto I. Characterization of α-glucosidase inhibitor/cyclodextrin complex prepared by freeze-drying. J Pharm. 2018;1-9.

Jagdale S, Suryawanshi V, Pandya S, Kuchekar B, Chabukswar A. Development of press-coated, floating-pulsatile drug delivery of lisinopril. Sci Pharm. 2014;82(2):423-440.

Jayaprabha KN, Joy PA. Citrate modified β-cyclodextrin functionalized magnetite nanoparticles: a biocompatible platform for hydrophobic drug delivery. RSC Adv. 2015;5(28):22117-22125.

Kfoury M, Landy D, Ruellan S, Auezova L, Greige-Gerges H, Fourmentin S. Determination of formation constants and structural characterization of cyclodextrin inclusion complexes with two phenolic isomers: carvacrol and thymol. Beilstein J Org Chem. 2016;12(1):29-42.

Khames A. Formulation and characterization of eplerenone nanoemulsion liquisolids, an oral delivery system with higher release rate and improved bioavailability. Pharmaceutics. 2019;11(40):1-18.

Kolkhof P, Barfacker L. Mineralocorticoid receptor antagonists: 60 years of research and development. J Endocrinol. 2017;234(1):T125-T140.

Krishnaveni B, Muthukumaran M, Krishnamoorthy B. Development and evaluation of pulsatile drugs delivery system containing montelukast sodium by press coated tablet using natural polyssacharides. Int J Adv Pharm Gen Res. 2013;1(2):41-51.

Kukadiya CG, Desai K, Swamy SM. Formulation, evaluation and optimization of press coated pulsatile tablet of Zaltoprofen for the treatment of rheumatoid arthritis. Pharma Sci Monit. 2014;5(2):153-179.

Kumar RS, Suresh A. Formulation and evaluation of diltiazem chronotherapeutic systems by press coating technology employing magnesium starch- a novel timed-release polymer. Indo Am J Pharm Sci. 2018;5(2):1133-1145.

Kumar S. Compression coating-an approach to colon-specific drug delivery: Mod Appl Bioequiv Availab. 2017;1(3):1-5.

Latha K, Uhumwangho MU, Sunil SA, Srikanth MV, Ramana KV. Development of an optimized losartan potassium press-coated tablets for chronotherapeutic drug delivery. Trop J Pharm Res. 2011;10(5):551-558.

Moghadam A, Ijaz M, Asim M, Mahmood A, Jelkmann M, Matuszczak B et al. Non-ionic thiolated cyclodextrins - the next generation. Int J Nanomed. 2018;13:4003-4013.

Nagar P, Singh K, Chauhan I, Verma M, Yasir M, Khan A, et al. Orally disintegrating tablets: formulation, preparation techniques and evaluation. J Appl Pharm Sci. 2011;1(04):35-45.

Nokhodchi A, Raja S, Patel P, Asare-Addo K. The Role of oral controlled release matrix tablets in drug delivery systems. BioImpacts. 2012;2(4):175-187.

Pagar KP, Vavia PR. Felodipine β-cyclodextrin complex as an active core for time delayed chronotherapeutic treatment of hypertension. Acta Pharm. 2012;62(3):395-410.

Patil DR, Ingole PG, Kripal S, Dalal DS. FTIR, 1H NMR Spectral, Powder X-ray diffraction and DSC studies of “β-cyclodextrin-para-Chlorobenzonitrile” Inclusion Complex. Res J Chem Sci. 2012;2(10):60-63.

Patil OA, Patil IS, Bilsakar VV, Randive DS, Bhutkar MA, Bhinge SD. Formulation and evaluation of valsartan pulsincap drug delivery system for treatment of hypertension. Asian J Pharm Technol. 2018;8(2):65-70.

Rabadia N, Tiwari A, Patel G, Virani V. The floating drug delivery system and its impact on calcium channel blocker: A review article. J Pharm Sci Technol. 2012;4(1):835-867.

Semalty M, Bisht T, Semalty A. A comparative study of triple-layered aceclofenac matrix tablets formulated using xanthan gum and guar gum. Int J Pharm Sci Nanotech. 2012;5(1):1621-1626.

Shah KR, Chaudhary SA, Mehta TA. Polyox (polyethylene oxide) multifunctional polymer in novel drug delivery system. Int J Pharm Sci Drug Res. 2014;6(2):95-101.

Sherje AP, Jadhav M. β-cyclodextrin-based inclusion complexes and nanocomposites of rivaroxaban for solubility enhancement. J Mater Sci Mater Med. 2018;29(186):1-8.

Singh AV, Nath LK, Mater J. Evaluation of compatibility of lamivudine with tablet excipients and a novel synthesized polymer. Environ Sci. 2011;2(3):243-250.

Swathi B, Manichandrika, Lillygrace BD, Harika A, Shivakumari E, Harika N, et al. Formulation and evaluation of pulsatile drug delivery system of nisoldipine. Int J Pharm Biol Sci. 2018;8(3):213-219.

Tan Q, He D, Wu M, Yang L. Ren Y, Liu J, et al. Characterization, activity, and computer modeling of a molecular inclusion complex containing rifaldazine. Int J Nanomed . 2013;8:477-484.

Zuheir A, Samein LH, Aiash N. Preparation and in vitro evaluation of metoclopramide HCL hollow-type suppository. Int J Pharm Pharm Sci. 2013;5:660-666.

Downloads

Published

2022-12-19

Issue

Section

Original Article

How to Cite

Pulsatile Chronotherapeutic Drug Delivery for Controlling Early Morning Surge in Blood Pressure; Effect of Coating on Eplerenone In-vitro, In- vivo Release and Urinary Na/K Ratio. (2022). Brazilian Journal of Pharmaceutical Sciences, 58. https://doi.org/10.1590/s2175-97902022e19306